Midwest Peptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are sold for research use only (RUO), are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.

A 39-amino acid dual agonist peptide targeting GIP and GLP-1 receptors, studied for metabolic regulation, glucose homeostasis, and body composition in clinical research. Premium Research Peptide.
🌻 Sunflower Summer Sale
30mg is buy one get one half off, applied automatically at checkout. Add 4 and two are half off, and so on.
Add $70.01 more to save 8% off
Bundle & Save
Discount applies automatically at checkout once your cart subtotal hits the tier.
For In Vitro Research Use Only — Not for Human or Veterinary Use
For Research Use Only: This compound is offered solely for in vitro laboratory research. It is not intended for diagnostic, therapeutic, or clinical use in humans or animals. Not for dietary, cosmetic, or veterinary applications. This product has not been evaluated by the FDA or any medical body.
⚠️ Disclaimer: All information provided is strictly educational. No claim of efficacy or safety is made. Buyers assume full responsibility for ensuring proper use under federal and local research guidelines.
Terms of Sale: By purchasing from Midwest Peptide, you affirm that you are a qualified researcher with the experience to safely handle and store research materials. All sales are final. The supplier is not liable for any misuse, misrepresentation, or unintended outcomes related to this product.
GLP-2 TZ is a research peptide also known as tirzepatide, a 39-amino-acid synthetic dual agonist that activates both GLP-1 and GIP receptors. It is classified as a dual incretin receptor agonist used in metabolic and endocrinology research. Supplied strictly for Research Use Only.
Yes. GLP-2 TZ and tirzepatide refer to the same molecule. The GLP-2 naming reflects its position in the GLP receptor agonist research class (single, dual, triple), while tirzepatide is the international nonproprietary name. Both names map to the identical 39-residue sequence.
GLP-2 TZ activates two receptors (GLP-1 and GIP) while GLP-1 SM activates only the GLP-1 receptor. Research models show the dual-receptor mechanism produces stronger effects on glucose handling and adipose tissue endpoints than single-receptor agonists.
Other research peptides in this category
Research articles and insights related to GLP-2 TZ

FDA restricted compounded GLP-2 TZ for human use when the shortage ended. The Research Use Only research peptide channel for GLP-2 TZ operates under entirely separate regulations.
May 5, 2026

The cheapest GLP-2 TZ for research is rarely the best value. Here is how to balance price against the analytical specifications that determine research utility.
May 5, 2026

GLP-2 TZ GLP-2 TZ sourcing guide covering supplier evaluation for a dual GLP-1 GIP receptor agonist and the Midwest Peptide research catalog. For research use only.
April 14, 2026

GLP-2 TZ beta-cell research covering glucose stimulated insulin secretion, beta-cell mass, glucolipotoxicity models, and dual incretin pharmacology in rodent studies. For research use only.
April 14, 2026
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
GLP-2 TZ is a dual GLP-1 / GIP receptor agonist. GLP-3 RT is a triple GLP-1 / GIP / glucagon receptor agonist. The added glucagon-receptor activity of GLP-3 RT distinguishes the two in research models studying energy expenditure and lipid metabolism.
GLP-2 TZ is used in preclinical research on metabolic regulation, glucose homeostasis, body composition partitioning, and incretin pathway pharmacology. All cited studies are conducted in rodent or in-vitro systems consistent with the molecule's RUO classification.
Every batch of GLP-2 TZ ships with a third-party COA verifying purity by HPLC (>=99%), identity by mass spectrometry, and lyophilized mass. The batch-specific COA is published on this product page before purchase.
Lyophilized GLP-2 TZ is stored at -20C for long-term storage and 2-8C for short-term use within 30 days. Avoid repeated freeze-thaw cycles, which can compromise peptide stability. Store in original sealed vials, protected from light.
Tirzepatide (the molecule's INN) has clinical approvals in some indications. The GLP-2 TZ supplied here is for laboratory and research use only and is not approved for diagnostic, therapeutic, or human use.